Hancock Whitney Corp Vericel Corp Transaction History
Hancock Whitney Corp
- $3.07 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
276Shares Held
48.8MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$423 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$201 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$183 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$128 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$124 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.48B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...